EVAXION BIOTECH A/S (EVAX)       2.18  +0.03 (+1.4%)

2.18  +0.03 (+1.4%)

US29970R1059 - ADR

EVAXION BIOTECH A/S2.18

NASDAQ:EVAX (11/30/2022, 7:00:02 PM)+0.03 (+1.4%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 11-14 2022-11-14/bmo Earnings (Next) N/A N/A
Ins Owners N/A Inst Owners 0.6%
Market Cap 52.27M Shares 23.98M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 86.67
IPO 02-05 2021-02-05

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

EVAX Daily chart

Company Profile

Evaxion Biotech A/S engages in the discovery and development of novel immunotherapies for cancer and infectious diseases. The firm decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Company Info

EVAXION BIOTECH A/S

Bredgade 34E, Copenhagen K

COPENHAGEN 1260

CEO: Lars Staal Webner

Employees: 61

Website: http://www.evaxion-biotech.com/

EVAX News

News Image13 days ago - Evaxion BiotechEvaxion annonce des résultats prometteurs pour l'essai clinique de phase 1/2a portant sur l'immunothérapie EVX-02 personnalisée en fonction de l'ADN contre le cancer

COPENHAGUE, Danemark, 18 nov. 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ : EVAX) (« Evaxion » ou la « Société »), une société de biotechnologie...

News Image13 days ago - Evaxion BiotechEvaxion gibt vielversprechende Ergebnisse der klinischen Phase 1/2a-Studie der personalisierten DNA-Krebsimmuntherapie EVX-02 bekannt

KOPENHAGEN, Dänemark, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) („Evaxion“ oder das „Unternehmen“), ein...

News Image14 days ago - Evaxion BiotechEvaxion announces promising results from Phase 1/2a clinical trial of personalized DNA cancer immunotherapy EVX-02News Image14 days ago - Evaxion BiotechEvaxion announces promising results from Phase 1/2a clinical trial of personalized DNA cancer immunotherapy EVX-02

COPENHAGEN, Denmark, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology...

News Image17 days ago - Evaxion BiotechEvaxion Announces Third Quarter 2022 Financial Results and Business UpdateNews Image17 days ago - Evaxion BiotechEvaxion Announces Third Quarter 2022 Financial Results and Business Update

Per Norlén, M.D., PhD. joined Evaxion as Chief Executive Officer in October Enrollment of the first patient in our global Phase 2b clinical trial of...

EVAX Twits

Here you can normally see the latest stock twits on EVAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example